Skip to main content
Erschienen in: BMC Public Health 1/2015

Open Access 01.12.2015 | Research article

Impact of tea drinking upon tuberculosis: a neglected issue

verfasst von: Mengshi Chen, Jing Deng, Wufei Li, Dan Lin, Congxu Su, Mian Wang, Xun Li, Benjamin Kwaku Abuaku, Hongzhuan Tan, Shi Wu Wen

Erschienen in: BMC Public Health | Ausgabe 1/2015

Abstract

Background

Tuberculosis (TB) is a global public health issue posing serious harm to the human health. Many studies have suggested that smoking and excessive alcohol consumption are risk factors for TB. Laboratory evidence suggests that EGCG in tea leaves can arrest the growth of tubercle bacillus. Can drinking tea lead to decreased susceptibility of TB in humans?

Methods

A total of 574 TB patients and 582 healthy controls were recruited to participate in this case–control study. Self-designed questionnaire was used to collect data. Unconditioned logistic regression analysis was conducted to identify the associations between tea drinking and TB.

Results

Tea drinking has a negative association with TB, with OR = 0.583(0.423, 0.804) and P < 0.05. Drinking black tea, oolong and green tea are all negative association with TB, with OR being 0.683(0.517, 0.902), 0.674(0.508, 0.894) and 0.534(0.349, 0.817) respectively and P < 0.05. Trend χ2 test indicated a decreasing risk for TB with increased tea consumption, with P < 0.05.

Conclusion

There is a significance negative association between tea drinking and TB. Promoting the consumption of tea as the daily drink among populations, particularly those with high TB risk, may reduce the incidence of TB in the populations.
Hinweise

Competing interests

The authors declare they have no competing interests.

Authors’ contribution

MC and HT designed the study and drafted the manuscript. CS and MW participated in the field investigation. XL, ABK and DL carried out the data analysis. JD and SWW supervised data analyses and results reporting. SWW, WL, XL and BKA assisted in the development of the research question and revision of the article. All authors read and approved the final manuscript.

Background

Tuberculosis is a global public health issue posing serious harm to the human health. It is estimated that there were 8.6 million TB patients in 2012 globally [1]. China has the second highest TB burden in the world. According to the 5th TB epidemiological sampling survey in 2010 in China [2], the TB prevalence was 459/100,000 among people aged 15 years and above.
Many studies have suggested that smoking and excessive alcohol consumption are risk factors for TB. To date, there is no population study focused on the impact of tea drinking on Tuberculosis. The biological functions of catechins contained in tea leaves have drawn much interest recently. Tea is the second most highly consumed beverage after water [3]. Many studies have shown that tea drinking is beneficial for health in addition to preventing, and in some cases, alleviating certain health ailments, including inflammatory response [46], obesity [79], cardiovascular diseases [1012], autoimmune diseases [1317], neurodegenerative diseases [18] and tumors [1922].
Laboratory evidence suggests that epigallocatechin-3-gallate (EGCG) in tea leaves can arrest the growth of tubercle bacillus by inhibiting the activity of InhA, the enoyl-acyl carrier protein reductase in tubercle bacillus [23]. It can also inhibit the survival of tubercle bacillus within macrophages by inhibiting the TACO (tryptophan-aspartate containing coat protein) gene transcription within macrophages [24]. The question then remains: Can drinking tea lead to decreased susceptibility of TB in humans? The case control study was used to explore the association between tea drinking and TB.

Methods

Sources of cases

Stratified sampling method was used to randomly select four county-level CDCs (i.e. Qidong County CDC, Yueyanglou District CDC, Yueyang County CDC and Hongjiang City CDC) using the random number table among 122 counties/cities/districts in Hunan Province, and then randomly select cases from all TB patients newly registered in 2009 by the four county-level CDCs. Cases of TB are diagnosed according to anatomical site of disease, bacteriological results, history of previous treatment and HIV status of the patient. Each of these key features of TB cases was discussed in World Health Organization Report [25]. Patients with HIV/TB co-infection were excluded. Patients who stopped receiving medications or were previously treated were also excluded.

Sources of healthy controls

Stratified sampling method was used to randomly select one community health service center (i.e. Xingang Community Health Service Center) using the random number table among 14 community health service centers in Kaifu District, Changsha City, and then randomly select one community (i.e. Xin'ansi Community) from six communities covered by Xingang Community Health Service Center. The control group consists of healthy people without abnormalities in chest X-ray. Because the ratio of male to female TB patients was about 2.5:1 in Hunan [26], the healthy controls were selected from permanent residents in Xin'ansi Community by a gender-age frequency matching method. All controls were confirmed free from active TB. Although the cases and controls was selected from different district, both of them is Han nationality, all the districts with the same TB control policy and measures, very close distance (in Hunan province), and very similar economic level and life manners and customs in different district population, such as in tea drinking habit.

Ethical statement

The work met relevant ethical guidelines. Written informed consent was obtained from all subjects of this research, in accordance with the guidelines of Central South University Ethics Review Committee. The protocol was also approved by Central South University Ethics Review Committee. Investigations were conformed to the principles outlined in the declaration of Helsinki.

Data collection

Self-designed questionnaire was used to collect data. All the TB patients were asked to recall the situation of exposures when they came to CDCs for the confirmed diagnosis of TB. Data on exposure to tea drinking were collected through self-reporting by participants. In the survey, the respondents were asked if they are regular tea drinkers, if so the major concerns then centered around their tea drinking habits including frequency, duration and tea leaf choices. Questions about average monthly tea consumption include: how many grams of tea leaves a consumer buys every time, how many family members drink the tea, and how long it takes for them to finish it. Exposure to tea drinking is defined as at least one cup of tea drinking per week on average for over six months. Average monthly tea consumption is calculated by the duration of this consumption from a certain number of family members of a certain amount of tea leaves.

Statistical analysis

Epidata3.0 was used to input data and SAS9.2 was used to analyze the data. Chi square test was conducted for the comparison of grouped data. Logistic regression was used for multivariate analysis. All tests of hypothesis were two tailed with a type 1 error rate fixed at 5 %.

Results

The study participants included 574 TB patients and 582 healthy controls. The TB patient group and the healthy control group exhibited no difference in statistical significance (P > 0.05) in terms of sex, age, marital status, education background and alcohol drinking; while the difference in terms of BMI, smoking, history of BCG vaccination and cooking with solid fuel was statistically significant (P < 0.05); tea drinking has significant negative association with TB (OR = 0.650, P < 0.05) (Table 1).
Table 1
Univariate analysis of demographic characteristics and associated risk factors in TB
  
TB Patients
Healthy controls
OR (95 % CI)
N (%)
N (%)
Sex
Male
427
74.39
410
70.45
 
Female
147
25.61
172
29.55
0.821(0.634,1.063)
Age (years)
19-30
73
12.72
85
14.60
Reference
31-50
219
38.15
205
35.22
1.244(0.862,1.794)
51-70
195
33.97
182
31.27
1.248(0.860,1.810)
71-84
87
15.16
110
18.90
0.921(0.605,1.402)
Marital status
Married
403
70.21
397
68.21
 
Other
171
29.79
185
31.79
0.911(0.709,1.169)
Education background
Primary school or below
234
40.77
239
41.07
Reference
Junior high school
178
31.01
182
31.27
0.999(0.759,1.314)
Senior high school or above
162
28.22
151
25.95
1.096(0.823,1.458)
BMI
<18.5
208
36.24
199
34.19
Reference
18.5-24.9
334
58.19
325
55.84
0.983(0.768,1.259)
≥25
32
5.57
58
9.97
0.528(0.329,0.847)*
Smoking
No
242
42.16
312
53.61
 
Yes
332
57.84
270
46.39
1.585(1.257,2.000)*
Alcohol drinking
No
477
83.10
496
85.22
 
Yes
97
16.90
86
14.78
1.173(0.855,1.609)
History of BCG vaccination
No
462
80.49
416
71.48
 
Yes
112
19.51
166
28.52
0.608(0.462,0.799)*
cooking with solid fuel
No
234
40.77
312
53.61
 
Yes
340
59.23
270
46.39
1.679(1.330,2.119)*
Tea drinking
No
301
52.44
243
41.75
 
Yes
273
47.56
339
58.25
0.650(0.515,0.820)*
*P < 0.05
To exclude possible confounding and explore all the determinants meantime, multivariate unconditioned logistic regression analysis was conducted by using sex, age, marital status, education background, BMI, and alcohol drinking as the covariates, smoking, history of BCG vaccination, cooking with solid fuel, and tea drinking as independent variables. Results show that tea drinking and History of BCG vaccination had a negative association with TB (OR = 0.583 and 0.598), smoking and cooking with solid fuel was the risk factor of TB (OR = 1.589 and 1.490) (Table 2).
Table 2
Multivariate Analysis of Associated Risk Factors in TB
 
Coefficient (β)
ORad (95 % CI)#
Tea drinking
−0.539
0.583 (0.423,0.804)*
Smoking
0.463
1.589 (1.179,2.142)*
History of BCG vaccination
−0.514
0.598 (0.428,0.836)*
cooking with solid fuel
0.399
1.490 (1.095,2.027)*
# Multivariate logistic regression model was used to adjust the covariates of sex, age, marital status, education background, BMI, and alcohol drinking.
*P < 0.05
The study was also conducted to ascertain the associations of different classes of tea on Tuberculosis. Tea leaves can be classified as black tea (fermented tea leaves), oolong (semi-fermented tea leaves) and green tea (unfermented tea leaves). The results indicate that drinking black tea, oolong and green tea almost had same negative associations with TB, with OR being 0.683, 0.674, and 0.534, respectively (P < 0.05). (Table 3)
Table 3
The association between types of tea leaves and TB
Type of tea leaves
TB Patients
Healthy controls
ORc (95 % CI)
ORad (95 % CI)#
N
%
N
%
Not drinking tea
301
52.44
243
41.75
Reference
Reference
Black tea
63
10.98
73
12.54
0.697 (0.478,1.016)
0.683 (0.517,0.902)*
Oolong
84
14.63
98
16.84
0.692 (0.494,0.969)*
0.674 (0.508,0.894)*
Green tea
126
21.95
168
28.87
0.605 (0.455,0.806)*
0.534 (0.349,0.817)*
#Multivariate logistic regression model was used to adjust the covariates of sex, age, marital status, education background, BMI, smoking, alcohol drinking, history of BCG vaccination and cooking with solid fuel.
*P < 0.05
Subjects who drank tea were categorized into three groups by monthly amount of tea drinking: 1-60 g group, 61-150 g group, and 151-300 g group, which would help investigate a dose–response relationship of tea consumption on TB. OR for 1-60 g group, 61-150 g group, 151-300 g group were 0.674, 0.619 and 0.564, respectively, with P < 0.05; trend χ2 test indicated a decreasing risk for TB with increased tea consumption, with P < 0.05, which showed significant dose–response relationship of tea consumption on TB (Table 4).
Table 4
The association between the quantity of tea consumption and TB
Tea consumption (g/month)
TB Patients
Healthy controls
ORc (95 % CI)
ORad (95 % CI)#
N
%
N
%
Not drinking tea
301
52.44
243
41.75
Reference
Reference
1-60
94
16.38
106
18.21
0.716(0.517,0.991)*
0.674(0.472,0.962)*
61-150
98
17.07
124
21.31
0.638(0.466,0.874)*
0.619(0.478,0.801)*
151-300
81
14.11
109
18.73
0.600(0.430,0.837)*
0.564(0.415,0.766)*
Trend χ 2  = 12.784, P = 0.000
#Multivariate logistic regression model was used to adjust the covariates of sex, age, marital status, education background, BMI, smoking, alcohol drinking, history of BCG vaccination and cooking with solid fuel.
*P < 0.05

Discussion

In this study, we found smoking, cooking with solid fuel had positive association with TB, but BCG vaccination and tea drinking had a negative association with TB. Many researches showed that smoking was an independent risk factor for tuberculosis (TB), and the risk of TB increases with increments of smoking, which support our result. Recent years, cooking with solid fuel has been regarded as another risk factor of TB, and has been confirmed in different populations [2730]. The protection conferred by the BCG vaccine is significantly greater when the vaccine is administered to neonates or school children. In children, protection against pulmonary TB can reach up to 80 % [31], however, only 50 % of adults are protected [32]. Our result supported that BCG vaccine would reduce the risk of TB, which is consistency in univariate and multivariate analysis.
Our main finding is that tea drinking had a negative association with TB. Interestingly, green tea afforded the most evident protection against TB, compared to other types of tea. In addition, increasing tea consumption is associated with a decreased risk of tuberculosis, showed significant dose–response relationship.
Tea leaves have high concentration in tea polyphenols, primarily consisting of flavonoids, such as flavanol monomers and flavanol gallates. Flavanol monomers mainly contain catechin, epicatechin and epigallocatechin. Flavanol gallates mainly contain epicatechin gallate and epigallocatechin-3-gallate (EGCG). These substances are most prevalent in tea leaves, while EGCG exhibits the strongest biological activity. The content of catechins can account for 30-40 % of the dry weight of fresh tea leaves [6], while the content of EGCG accounts for 50-80 % of the total catechins in tea leaves [33]. Green tea is not fermented, and the content of the catechins contained in green tea is higher than that in semi-fermented (oolong) and fermented (black tea) tea leaves.
Numerous studies suggest that tea drinking helps to prevent obesity [79], cardiovascular diseases [1012], autoimmune diseases [1317], neurodegenerative diseases [18], tumors [1922]. To our knowledge, this is the first study that discovered the negative association between tea drinking and TB in human population, moreover, showed significant dose–response relationship. The negative association of tea drinking and TB is postulated to occur via the following mechanisms: Firstly, the EGCG in tea leaves inhibit the growth of tubercle bacillus by inhibiting the activity of InhA, the enoyl-acyl carrier protein reductase [23, 34, 35]. Secondly, EGCG in tea leaves weakens the transcription of TACO genes in human macrophages by inhibiting the activity of SP1 transcription factors in TACO gene promoters, thereby weakening the expression of TACO genes, which in turn inhibit the survival of tubercle bacillus in macrophages [24]. Therefore, EGCG supplementation is of key significance for the prevention of tubercle bacillus infection. However, more researches in other population or more basic mechanism researches were required.
There are some limitations in our study. Firstly, we did not collected information on TB contact information. Secondly, the cases and controls in our study were sampled from different regions. Because the different sampling district have very similar background and condition; the possible impacts of non-genetic factors such as sex, age, marital status, educational background, BMI, smoking, alcohol drinking, history of BCG vaccination and cooking with solid fuel were adjusted by multivariate logistic regression; and dose–response relationship was observed. So the results observed in our study should be reliable.

Conclusions

Tea drinking perhaps was a protective factor against Tuberculosis. Although substantial efforts are yet to be made to explore the mechanism of action, this study indicated that tea drinking perhaps could have very important effect on prevent and control TB infection. Tea is highly affordable, convenient and popular. Promoting the consumption of tea as the daily drink among populations, particularly those with high TB risk, may reduce the risk of TB in the population. Especially in developing countries with high TB prevalence, this approach may bring about significant social and economic benefits.

Acknowledgements

We thank our partners Dr Liqiong Bai (Hunan Institute of Tuberculosis Prevention and Treatment), and Ying Liang (School of Public Health, Central South University) for their input into this work.

Financial support

This investigation was supported by Fundamental Research Funds for the Central South University and Global Foundation for China’s Implementation Research in TB (GRANT 07-062).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare they have no competing interests.

Authors’ contribution

MC and HT designed the study and drafted the manuscript. CS and MW participated in the field investigation. XL, ABK and DL carried out the data analysis. JD and SWW supervised data analyses and results reporting. SWW, WL, XL and BKA assisted in the development of the research question and revision of the article. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat WHO. Global tuberculosis report 2013. Geneva: WHO; 2013. WHO. Global tuberculosis report 2013. Geneva: WHO; 2013.
2.
Zurück zum Zitat Survey TGGotFNTE, Survey TOotFNTE. The Fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(8):485–508. Survey TGGotFNTE, Survey TOotFNTE. The Fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(8):485–508.
3.
Zurück zum Zitat Graham HN. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine. 1992;21(3):334–50.CrossRefPubMed Graham HN. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine. 1992;21(3):334–50.CrossRefPubMed
4.
Zurück zum Zitat Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, Mangeshkar P, et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. European Journal of Pharmacology. 2008;579(1–3):411–7.CrossRefPubMed Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, Mangeshkar P, et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. European Journal of Pharmacology. 2008;579(1–3):411–7.CrossRefPubMed
5.
Zurück zum Zitat Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother. 2008;62(3):189–96.CrossRefPubMed Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother. 2008;62(3):189–96.CrossRefPubMed
6.
Zurück zum Zitat de Mejia EG, Ramirez-Mares MV, Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain, Behavior, and Immunity. 2009;23(6):721–31.CrossRefPubMed de Mejia EG, Ramirez-Mares MV, Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain, Behavior, and Immunity. 2009;23(6):721–31.CrossRefPubMed
7.
Zurück zum Zitat Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. The Journal of Nutrition. 2008;138(9):1677–83.PubMedPubMedCentral Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. The Journal of Nutrition. 2008;138(9):1677–83.PubMedPubMedCentral
8.
Zurück zum Zitat Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obesity (2005). 2005;29(6):615–23.CrossRef Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obesity (2005). 2005;29(6):615–23.CrossRef
9.
Zurück zum Zitat Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Annals of nutrition & metabolism. 2005;49(1):54–63.CrossRef Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Annals of nutrition & metabolism. 2005;49(1):54–63.CrossRef
10.
Zurück zum Zitat Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, et al. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundamental & Clinical Pharmacology. 2008;22(3):275–84.CrossRef Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, et al. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundamental & Clinical Pharmacology. 2008;22(3):275–84.CrossRef
11.
Zurück zum Zitat Lou FQ, Zhang MF, Zhang XG, Liu JM, Yuan WL. A study on tea-pigment in prevention of atherosclerosis. Chinese Medical Journal. 1989;102(8):579–83.PubMed Lou FQ, Zhang MF, Zhang XG, Liu JM, Yuan WL. A study on tea-pigment in prevention of atherosclerosis. Chinese Medical Journal. 1989;102(8):579–83.PubMed
12.
Zurück zum Zitat Jochmann N, Baumann G, Stangl V. Green tea and cardiovascular disease: from molecular targets towards human health. Current Opinion in Clinical Nutrition and Metabolic Care. 2008;11(6):758–65.CrossRefPubMed Jochmann N, Baumann G, Stangl V. Green tea and cardiovascular disease: from molecular targets towards human health. Current Opinion in Clinical Nutrition and Metabolic Care. 2008;11(6):758–65.CrossRefPubMed
13.
Zurück zum Zitat Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, et al. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. The Journal of Nutrition. 2008;138(11):2111–6.CrossRefPubMedPubMedCentral Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, et al. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. The Journal of Nutrition. 2008;138(11):2111–6.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. The American Journal of Pathology. 2012;180(1):221–34.CrossRefPubMed Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. The American Journal of Pathology. 2012;180(1):221–34.CrossRefPubMed
15.
Zurück zum Zitat Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(38):14692–7.CrossRefPubMedPubMedCentral Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(38):14692–7.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. Journal of Immunology. 2004;173(9):5794–800.CrossRef Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. Journal of Immunology. 2004;173(9):5794–800.CrossRef
17.
Zurück zum Zitat Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(8):4524–9.CrossRefPubMedPubMedCentral Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(8):4524–9.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2003;17(8):952–4. Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2003;17(8):952–4.
19.
Zurück zum Zitat Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Research. 2005;65(22):10623–31.CrossRefPubMed Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Research. 2005;65(22):10623–31.CrossRefPubMed
20.
Zurück zum Zitat Yang CS, Liao J, Yang GY, Lu G. Inhibition of lung tumorigenesis by tea. Experimental Lung Research. 2005;31(1):135–44.CrossRefPubMed Yang CS, Liao J, Yang GY, Lu G. Inhibition of lung tumorigenesis by tea. Experimental Lung Research. 2005;31(1):135–44.CrossRefPubMed
21.
Zurück zum Zitat Kundu JK, Surh YJ. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Annals of the New York Academy of Sciences. 2007;1095:504–12.CrossRefPubMed Kundu JK, Surh YJ. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Annals of the New York Academy of Sciences. 2007;1095:504–12.CrossRefPubMed
22.
Zurück zum Zitat Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, Ahmad N, et al. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2009;15(6):1947–53.CrossRef Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, Ahmad N, et al. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2009;15(6):1947–53.CrossRef
23.
Zurück zum Zitat Sharma SK, Kumar G, Kapoor M, Surolia A. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications. 2008;368(1):12–7.CrossRefPubMed Sharma SK, Kumar G, Kapoor M, Surolia A. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications. 2008;368(1):12–7.CrossRefPubMed
24.
Zurück zum Zitat Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. The International Journal of Biochemistry & Cell Biology. 2006;38(4):600–9.CrossRef Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. The International Journal of Biochemistry & Cell Biology. 2006;38(4):600–9.CrossRef
25.
Zurück zum Zitat WHO: Treatment of tuberculosis: guidelines - 4th ed. Geneva, WHO 2010. WHO: Treatment of tuberculosis: guidelines - 4th ed. Geneva, WHO 2010.
26.
Zurück zum Zitat Chen M, Kwaku AB, Chen Y, Huang X, Tan H, Wen SW. Gender and regional disparities of tuberculosis in Hunan, China. Int Journal for Equity in Health. 2014;13:32.CrossRef Chen M, Kwaku AB, Chen Y, Huang X, Tan H, Wen SW. Gender and regional disparities of tuberculosis in Hunan, China. Int Journal for Equity in Health. 2014;13:32.CrossRef
27.
Zurück zum Zitat Lakshmi PV, Virdi NK, Thakur JS, Smith KR, Bates MN, Kumar R. Biomass fuel and risk of tuberculosis: a case–control study from Northern India. Journal of Epidemiology and Community Health. 2012;66(5):457–61.CrossRefPubMed Lakshmi PV, Virdi NK, Thakur JS, Smith KR, Bates MN, Kumar R. Biomass fuel and risk of tuberculosis: a case–control study from Northern India. Journal of Epidemiology and Community Health. 2012;66(5):457–61.CrossRefPubMed
28.
Zurück zum Zitat Sumpter C, Chandramohan D. Systematic review and meta-analysis of the associations between indoor air pollution and tuberculosis. Tropical Medicine & International Health : TM & IH. 2013;18(1):101–8.CrossRef Sumpter C, Chandramohan D. Systematic review and meta-analysis of the associations between indoor air pollution and tuberculosis. Tropical Medicine & International Health : TM & IH. 2013;18(1):101–8.CrossRef
29.
Zurück zum Zitat Garcia-Sancho MC, Garcia-Garcia L, Baez-Saldana R, Ponce-De-Leon A, Sifuentes-Osornio J, Bobadilla-Del-valle M, et al. Indoor pollution as an occupational risk factor for tuberculosis among women: a population-based, gender oriented, case–control study in Southern Mexico. Rev Invest Clin; Organo del Hospital de Enfermedades de la Nutricion. 2009;61(5):392–8. Garcia-Sancho MC, Garcia-Garcia L, Baez-Saldana R, Ponce-De-Leon A, Sifuentes-Osornio J, Bobadilla-Del-valle M, et al. Indoor pollution as an occupational risk factor for tuberculosis among women: a population-based, gender oriented, case–control study in Southern Mexico. Rev Invest Clin; Organo del Hospital de Enfermedades de la Nutricion. 2009;61(5):392–8.
30.
Zurück zum Zitat Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case–control study. Thorax. 2009;64(8):705–8.CrossRefPubMed Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case–control study. Thorax. 2009;64(8):705–8.CrossRefPubMed
31.
Zurück zum Zitat Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2014;58(4):470–80.CrossRef Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2014;58(4):470–80.CrossRef
32.
Zurück zum Zitat Principi N, Esposito S. The present and future of tuberculosis vaccinations. Tuberculosis. 2015;95(1):6–13.CrossRefPubMed Principi N, Esposito S. The present and future of tuberculosis vaccinations. Tuberculosis. 2015;95(1):6–13.CrossRefPubMed
33.
Zurück zum Zitat Pae M, Wu D. Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. Food & Function. 2013;4(9):1287–303.CrossRef Pae M, Wu D. Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. Food & Function. 2013;4(9):1287–303.CrossRef
34.
Zurück zum Zitat Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. Journal of Biological Chemistry. 2004;279(30):30994–1001.CrossRefPubMed Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. Journal of Biological Chemistry. 2004;279(30):30994–1001.CrossRefPubMed
35.
Zurück zum Zitat Sharma SK, Parasuraman P, Kumar G, Surolia N, Surolia A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). Journal of Medicinal Chemistry. 2007;50(4):765–75.CrossRefPubMed Sharma SK, Parasuraman P, Kumar G, Surolia N, Surolia A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). Journal of Medicinal Chemistry. 2007;50(4):765–75.CrossRefPubMed
Metadaten
Titel
Impact of tea drinking upon tuberculosis: a neglected issue
verfasst von
Mengshi Chen
Jing Deng
Wufei Li
Dan Lin
Congxu Su
Mian Wang
Xun Li
Benjamin Kwaku Abuaku
Hongzhuan Tan
Shi Wu Wen
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2015
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1855-6

Weitere Artikel der Ausgabe 1/2015

BMC Public Health 1/2015 Zur Ausgabe